Brady Corp (BRC) stock
BRCNYSEMiscellaneous Manufacturing IndustriesFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Sep 3, 2026Score 13/3014% above fair value
$82.62+0.22 (+0.27%)
Close on Nov 12, 2026Market cap $3.87BP/E 19.2Yield –
Brady EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Brady's EPS for the twelve months ending Jul 31, 2026 was $4.31, up 9.7% year over year.
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $0.96 | -7.7% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $1.21 | +11.0% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $1.01 | +21.7% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $1.13 | +16.5% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $1.04 | -9.6% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $1.09 | +3.8% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $0.83 | -7.8% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $0.97 | 0.0% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $1.15 | +15.0% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $1.05 | +9.4% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $0.90 | +18.4% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $0.97 | +22.8% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $1.00 | +23.5% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $0.96 | +23.1% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $0.76 | +16.9% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $0.79 | +17.9% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $0.81 | +52.8% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $0.78 | +9.9% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $0.65 | +10.2% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $0.67 | +4.7% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $0.53 | 0.0% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $0.71 | +173.1% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $0.59 | -4.8% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $0.64 | -8.6% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $0.53 | -22.1% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $0.26 | -60.0% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $0.62 | +12.7% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $0.70 | +20.7% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $0.68 | +1.5% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $0.65 | +32.7% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $0.55 | +587.5% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $0.58 | +18.4% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $0.67 | +39.6% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $0.49 | +14.0% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $0.08 | -83.7% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $0.49 | +11.4% |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $0.48 | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $0.43 | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $0.49 | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | $0.44 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?